Lazure Scientific, Inc.
We have developed a revolutionary device to treat prostate cancer without life altering side effects (currently in human clinical trials).
- Stage Prototype Ready
- Industry Medical Devices and Equipment
- Location Issaquah, WA, USA
- Currency USD
- Founded December 2006
- Employees 2
- Website LazureScientific.com
Company Summary
Current prostate cancer treatments (surgery, radiation) result in extremely high rates of urinary incontinence and sexual side effects. Prostate cancer is the most common cancer in men with over 240K men diagnosed and over 30K deaths annually in the USA. A whole gland treatment, such as ours, without side effects would provide for an extremely significant competitive advantage over current treatments and would provide men a better option.
Team
-
Charles HillPresident and CEO
24+ years of business and executive management experience. Formerly with KPMG (CPA) and Pistol Creek Company (a privately held investment company). Designed and oversees all aspects of preclinical testing as well as human clinical trials. Selected, engaged, and oversees all regulatory and clinical trial management consultants. Develop and manage patent strategies and counsel. Work closely with engineering/design device development team.
-
Joshua HockettChief Technology Officer
10+ years of engineering and system design experience. Formerly with Synapse Product Development. Expert mechanical and electrical engineering specialist with extensive medical device development experience. Lead architect/designer for all preclinical and clinical devices. Oversees and engages all external engineering/design teams. Participates in physician and hospital staff training at clinical trial site locations.
-
Dr. Paul LangeChief Medical Advisor
Dr. Lange graduated from Washington University Medical School and received his general surgery and urology training at the University of Rochester, Duke University and the University of Minnesota. In 1988, Dr. Lange moved to the University of Washington as Professor and Chairman of the Department of Urology, a position held for 19 years. Dr. Lange is extensively published and was formerly on the New England Journal of Medicine editorial board.
Advisors
-
Daren Nitz - General, Mike Rosato (Wilson Sonsini) - PatentLawyerUnconfirmedRick Cooley - Clark Nuber PSAccountantUnconfirmed
Previous Investors
-
High Net Worth Individuals OnlyUnconfirmed
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.